NATERA, INC. Proceeds from Sale of Available-for-sale Securities
NATERA, INC. (NTRA) reported Proceeds from Sale of Available-for-sale Securities of $37.39 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2019-11-08
- NATERA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- NATERA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-09-30 was $9.49M, a 48.86% decline year-over-year.
- NATERA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-06-30 was -$1.00K, a 100.01% decline year-over-year.
- NATERA, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-03-31 was $27.90M, a 11.35% increase year-over-year.
- NATERA, INC. proceeds from sale of available-for-sale securities for fiscal 2018 was $37.39M, a 42.72% decline from fiscal 2017.
- NATERA, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $65.27M, a 10.28% increase from fiscal 2016.
- NATERA, INC. proceeds from sale of available-for-sale securities for fiscal 2016 was $59.19M.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $9.49M derived: sum of 2 quarters · filed 2019-11-08 | $9.49M derived: sum of 3 quarters · filed 2019-11-08 | $37.39M 10-K · filed 2019-03-15 |
| 2018-09-30 | $9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $9.49M derived: sum of 2 quarters · filed 2019-11-08 | $37.39M 10-Q · filed 2019-11-08 | $47.30M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $27.89M 10-Q · filed 2019-08-09 | $37.81M derived: sum of 3 quarters · filed 2019-08-09 | $56.37M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $27.90M 10-Q · filed 2019-05-10 | $37.81M derived: sum of 2 quarters · filed 2019-05-10 | $56.38M derived: sum of 3 quarters · filed 2019-05-10 | $68.11M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $9.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $28.48M derived: sum of 2 quarters · filed 2019-03-15 | $40.22M derived: sum of 3 quarters · filed 2019-03-15 | $65.27M 10-K · filed 2019-03-15 |
| 2017-09-30 | $18.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $30.30M derived: sum of 2 quarters · filed 2018-11-09 | $55.35M 10-Q · filed 2018-11-09 | $55.35M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $11.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $36.79M 10-Q · filed 2018-08-09 | $36.79M derived: sum of 3 quarters · filed 2019-03-15 | $79.21M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $25.05M 10-Q · filed 2018-05-10 | $25.05M derived: sum of 2 quarters · filed 2019-03-15 | $67.47M derived: sum of 3 quarters · filed 2019-03-15 | $73.64M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $42.42M derived: sum of 2 quarters · filed 2019-03-15 | $48.59M derived: sum of 3 quarters · filed 2019-03-15 | $59.19M 10-K · filed 2019-03-15 |
| 2016-09-30 | $42.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $48.59M derived: sum of 2 quarters · filed 2017-11-09 | $59.19M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $6.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $16.77M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $10.60M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |